Navigation Links
IDM Pharma Joins NORD to Raise Awareness of Rare Diseases
Date:2/26/2009

IRVINE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI) today announced that it is joining the National Organization for Rare Disorders (NORD) and more than 100 patient organizations, caregivers, researchers and companies developing treatments for rare diseases to observe Rare Disease Day on February 28. The goal of the day is to bring attention to rare diseases, the challenges encountered by those affected and the importance of research to develop diagnostics and treatments. IDM Pharma is currently developing mifamurtide (MEPACT in Europe) for the treatment of osteosarcoma, a rare bone cancer in children and young adults.

"Osteosarcoma impacts approximately 1,200 newly diagnosed children and young adults every year in each of the United States and Europe," said Robert W. Metz, vice president, commercial operations, IDM Pharma. "Through our participation in Rare Disease Day, we hope to bring increased attention to the impact rare diseases -- like osteosarcoma -- have on the lives of young patients and their families, and help break down the barriers some patients experience when trying to access proper diagnosis and treatment."

IDM Pharma has developed mifamurtide to treat non-metastatic, resectable osteosarcoma. The Company is currently awaiting a final decision on European Marketing Authorization, anticipated within the first quarter, following the positive opinion adopted by the Committee for Medicinal Products for Human Use in December 2008. The submission was based, in part, on the largest Phase 3 clinical trial ever completed in osteosarcoma, which enrolled approximately 800 patients and was a National Cancer Institute (NCI) funded cooperative group study conducted by the Children's Oncology Group (COG). The study evaluated patient outcomes with the addition of mifamurtide t
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Access Pharmaceuticals Closes Acquisition of MacroChem Corp.
2. Shengtai Pharmaceutical, Inc. Comments On Its Operations
3. The Quigley Corporation Reports Fourth Quarter and 2008 Annual Results; Continues To Invest In Pharmaceutical R&D Future
4. PharmaNet Development Group Reports Fourth Quarter and Full Year 2008 Preliminary Financial Results
5. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
6. Par Pharmaceutical to Host Fourth Quarter and Full Year 2008 Results Conference Call on March 3 at 9:00 am
7. Pharmacists Encourage Patients To Seek Their Guidance When Choosing OTC Medications
8. Health experts urge supermarket pharmacies to get smart about free antibiotics
9. Aton Pharma Acquires U.S. TIMOPTIC(R)
10. New Momentum Launches Anti-Counterfeiting Software for Pharmaceutical Companies
11. Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsukas Pharmaceutical Business Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... Carepoint has been designed specifically to facilitate ... intuitive interface for recording, sending, displaying and receiving ... reporting features. , Hall mc - an Ontario-based ... Rebecca de Witte to create this exciting new ... Carepoint provides seamless, real-time communication between the ...
(Date:7/14/2014)... COPENHAGEN Participation in activities that promote mental ... may help protect against the development of Alzheimer,s ... new research reported today at the Alzheimer,s Association ... , Research reported at AAIC 2014 also showed ... post-traumatic stress disorder (PTSD) may increase dementia ...
(Date:7/14/2014)... 2014 Spine Team Texas ... care—from diagnosis to treatment and recovery. Currently all physical ... in or training for certification in The McKenzie Method. ... completed the extensive program. , “We require certification of ... results in better outcomes for spine pain patients,” said ...
(Date:7/14/2014)... July 14, 2014 Cadeon Associates ... Turning Information into Money,” today announced that it ... global program that helps partners resell, deploy, and ... Spotfire® analytics platform. TIBCO Software Inc. is a ... including TIBCO Spotfire analytics, providing businesses the ability ...
(Date:7/13/2014)... Recently, TopDresses100.com, a popular dress company in the ... multi-colored Quinceanera dresses to its product line. According ... outfits are guaranteed to be quality made. Now, they ... , TopDresses100.com has a wide variety of elegant dresses ... are in stock and ready to ship. As an ...
Breaking Medicine News(10 mins):Health News:Home Health Care Professional and Marketing Firm Team Up to Create New Homecare Communication App 2Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 2Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 3Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 4Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 5Health News:Potential Alzheimer's disease risk factor and risk reduction strategies become clearer 6Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 2Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 3Health News:Cheap Multi-colored Quinceanera Dresses From TopDresses100.com 2
... of different alcoholic beverages and drinking behaviour on the risk ... and Cohort of Swedish Men, to study the association between ... acute pancreatitis. In total, 84,601 individuals, aged 46-84 years, ... 513 developed acute pancreatitis. There was a doseresponse association ...
... Aug. 11 (HealthDay News) -- The HIV infection rate among ... of AIDS is 10 to 20 times greater than in ... Two percent of poor heterosexuals in those cities have ... Prevention researchers, analysis of National HIV Behavioral Surveillance System data. ...
... (WASHINGTON, August 11, 2011) According to a study ... of the American Society of Hematology (ASH), researchers ... drug that releases stem cells from the bone marrow into ... at risk for later development of abnormalities involving loss or ...
... THURSDAY, Aug. 11 (HealthDay News) -- Symptoms of Alzheimer,s ... 80, according to a new study that examined the ... The study included 105 Alzheimer,s patients and 125 ... 60 to 75 (young-old) and those 80 and older ...
... Mann HealthDay Reporter , WEDNESDAY, Aug. 10 (HealthDay ... people with an irregular heartbeat may give the old standby, ... an erratic heartbeat known as atrial fibrillation are at increased ... such as a blood clot. For this reason, they have ...
... release is available in French . , ROCKVILLE, ... Oxford-Emergent Tuberculosis Consortium (OETC) announce today the start of a ... (TB) vaccine that involves people living with the human immunodeficiency ... sites in Senegal and South Africa with primary funding support ...
Cached Medicine News:Health News:Alcohol consumption in relation to acute pancreatitis 2Health News:Poor, Urban Heterosexuals at High Risk of HIV: CDC 2Health News:Stem cell mobilization therapy found to be safe for bone marrow donors 2Health News:Stem cell mobilization therapy found to be safe for bone marrow donors 3Health News:Alzheimer's Harder to Detect in the Very Old 2Health News:Study Pits New Blood Thinner Against Warfarin For Irregular Heartbeat 2Health News:Study Pits New Blood Thinner Against Warfarin For Irregular Heartbeat 3Health News:Study Pits New Blood Thinner Against Warfarin For Irregular Heartbeat 4Health News:New TB vaccine enters proof-of-concept trial in people living with HIV 2Health News:New TB vaccine enters proof-of-concept trial in people living with HIV 3
(Date:7/11/2014)... July 11, 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has ... solution for use in portable vaporizers, which contains ... ingredients in cannabis, cannabidiol offers consumers a THC-free ... and other vaporizer technology. Photo - ... contains 483 different compounds which are currently known, ...
(Date:7/11/2014)... 2014 Research and Markets has ... Medical X-ray Film Industry Report 2014" report to ... Global And Chinese Medical X-Ray Film Industry ... the current state of the Global medical X-ray film ... The report provides a basic overview of the industry ...
(Date:7/11/2014)... July 11, 2014  Australian drug delivery company, Phosphagenics ... has raised A$19.3 million via a placement of A$16.3 ... , the U.S., Asia and ... a share purchase plan (SPP) to be offered to ... made in two tranches. "This capital raising ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2Global and Chinese Medical X-ray Film Industry Report 2014 2Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3
... Sept. 28 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... on the topic "Eye Diseases: Novel Therapies for Wet ... Citi,s 5th Annual Biotech Day on Tuesday, October 5, ... 8:00 a.m. Eastern Time and may be accessed through ...
... Inc. today announced that the U.S. Patent and ... another key patent application, "Mechanical Method and Apparatus ... matter covering the method of the INSORB Skin ... has now sold over 500,000 INSORB® Absorbable Skin ...
Cached Medicine Technology:Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent 2Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: